Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
May 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
Femasys received CE Mark approval for its FemHSG Catheter, expanding the company's fertility diagnostics portfolio into the European market.
May 13, 2026
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter
Globe Newswire
Read ↗
May 8, 2026
Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update
GLOBE NEWSWIRE
Read ↗
May 5, 2026
Femasys Enables OB/GYNs to Deliver First-Line Fertility Treatment with Initial Commercial Use of FemaSeed Complete
GLOBE NEWSWIRE
Read ↗
Apr 22, 2026
Femasys Launches FemaSeed® Complete for OB/GYNs at ACOG 2026
Globe Newswire
Read ↗
Apr 16, 2026
Femasys Shareholder Update – Q1 2026
Femasys Inc.
Read ↗
Apr 16, 2026
Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio
GLOBE NEWSWIRE
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.